McDermott Will & Emery represented Ryvu Therapeutics in the transaction.Ryvu Therapeutics S.A. entered into an exclusive license agreement with Exelixis. The cooperation is focused on the development…
This content is for Standard 1 Year members only. LoginJoin Now
Author: Laura Testa
…
This content is for Standard 1 Year members only. LoginJoin Now